Search for: "Abbott v. Forward Design" Results 41 - 60 of 83
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Nov 2014, 5:52 am
  It was actually more directed to the effect of warnings on design defect claims than on warning claims themselves. [read post]
30 Dec 2013, 5:25 am
  The implied preemption rationale that design claims demand the “impossible” because design changes require FDA preapproval isn’t limited to generic drugs. [read post]
8 Jan 2013, 9:04 am by Abbott & Kindermann
Abbott, Diane Kindermann, Elizabeth Strahlstrom, Katherine J. [read post]
28 Dec 2012, 1:57 pm by Bexis
  Nor does information designed for patient consumption in any way trump the learned intermediary rule. [read post]
14 Aug 2012, 3:34 am
Case: Liversidge v Owen Mumford Ltd and Abbott Laboratories Ltd [2012] EWPCC 33, 26 July 2012. [read post]
12 Apr 2011, 12:55 pm by Joel R. Brandes
(The Office of Citizens Consular Services in the Bureau of Consular Affairs is designated as the U.S. [read post]
30 Aug 2010, 6:20 pm
Abbott Laboratories, 124 F.3d 1419 (Fed. [read post]